The Ruth Bader Ginsburg Corporate Board Award honors corporations for excellence in corporate governance, as illustrated by the critical mass of women directors on their boards, which include at least one lawyer-director.
DirectWomen is proud to present its 2024 Ruth Bader Ginsburg Board Diversity Award to Hewlett Packard Enterprise (HPE). President and CEO Antonio Neri will accept the award on behalf of the corporation. Pamela L. Carter, a DirectWomen 2018 Sandra Day O’Connor Board Excellence Award honoree, and Hewlett Packard Enterprise director, will also attend the Luncheon.
DirectWomen is proud to present its 2023 Ruth Bader Ginsburg Board Diversity Award to Cardinal Health, Inc. As of 2022, seven of Cardinal Health’s twelve independent directors are women. In addition, Cardinal Health’s board includes two women lawyers. Cardinal Health is one of only a handful of Fortune 500 companies with a female-majority board.
DirectWomen is proud to present its 2022 Board Diversity Award to Hasbro, Inc. As of 2022, Hasbro, Inc.’s board includes seven women directors, one of
DirectWomen is proud to present its 2021 Board Diversity Award to ViacomCBS. As of 2020, ViacomCBS’s board includes seven women directors, four of whom hold
DirectWomen is proud to present its 2019 Board Diversity Award to PNC. As of 2019, PNC’s board includes four women directors, one of whom holds a J.D. Three
DirectWomen was proud to present its 2018 Board Diversity Award to ConocoPhillips. As of 2018, the board of ConocoPhillips included four women directors, one of
Carol DiBattiste is an experienced public company executive, senior government official, and board director. She has an extensive track record of success in strategy, problem solving, cybersecurity, risk management, compliance,
Sandra Phillips Rogers is a seasoned executive and public company board member with a breadth of experience strategically managing complex corporate issues, integrating business, legal and stakeholder relations to achieve
Catherine is a board member and consultant with extensive global healthcare experience. She is an independent director of the Board of Meridian Bioscience, Inc. (NASDAQ: VIVO) and of Vascugen, Inc.
